Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
4
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
1 competitor in Enuresis
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Vlustozik (previously Ibuprofen Gen.Orph)
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age
View on EMAIbuprofen Gen.Orph
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age
View on EMAPedea
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
View on EMA